Sarepta Therapeutics
SRPT
SRPT
186 hedge funds and large institutions have $2.59B invested in Sarepta Therapeutics in 2016 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 54 increasing their positions, 52 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 52
33% less call options, than puts
Call options by funds: $524M | Put options by funds: $780M
Holders
186
Holding in Top 10
11
Calls
$524M
Puts
$780M
Top Buyers
| 1 | +$105M | |
| 2 | +$100M | |
| 3 | +$99M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$42.8M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$39.3M |
Top Sellers
| 1 | -$31.9M | |
| 2 | -$29.7M | |
| 3 | -$22.8M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$20.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.5M |